BTG1在78例口腔鳞癌中的表达及临床意义

doi:10.19439/j.sjos.2021.02.006

上海口腔医学 ›› 2021, Vol. 30 ›› Issue (2): 140-144.doi: 10.19439/j.sjos.2021.02.006

BTG1在78例口腔鳞癌中的表达及临床意义

靳能皓¹, 南欣荣^1,2, 闫星泉²

1.山西医科大学口腔医学院,山西太原 030001;
2.山西医科大学第一医院口腔科,山西太原 030001

收稿日期:2019-09-05 修回日期:2020-01-19 出版日期:2021-04-25 发布日期:2021-05-11
通讯作者: 南欣荣,E-mail：xr-nan@sina.com
作者简介:靳能皓（1994-）,男,在读硕士研究生,E-mail：545192726@qq.com
基金资助:
山西省重点研发计划项目（201803D31094）

Expression and clinical significance of BTG-1 in 78 patients with oral squamous cell carcinoma

JIN Neng-hao¹, NAN Xin-rong^1,2, YAN Xing-quan²

1. Shanxi Medical University School of Stomatology. Taiyuan 030001;
2. Department of Stomatology, The First Hospital of Shanxi Medical University. Taiyuan 030001, Shanxi Province, China

Received:2019-09-05 Revised:2020-01-19 Online:2021-04-25 Published:2021-05-11

摘要/Abstract

摘要： 目的:探讨B细胞易位基因1(BTG1)在口腔鳞状细胞癌中的表达及临床意义。方法:采用免疫组织化学染色检测78例口腔鳞癌组织、78例癌旁组织、20例正常口腔黏膜组织及80例颈淋巴结中BTG1蛋白的表达水平;使用蛋白免疫印迹及实时荧光定量PCR分别检测78例口腔鳞癌组织及癌旁组织中BTG1蛋白及mRNA的表达水平。采用SPSS 21.0软件包对数据进行统计学分析,包括Kaplan-Meier生存分析、Log rank检验及Cox回归分析。结果:口腔鳞癌组织及颈部阳性淋巴结中BTG1的表达水平显著低于癌旁正常组织及阴性淋巴结,低分化口腔鳞癌中BTG1的表达水平显著低于高分化鳞癌（P<0.05）。生存分析显示,BTG1低表达组无进展生存期（PFS）、总体生存时间（OS）显著低于高表达组（P<0.05）。Cox回归分析显示,肿瘤分化程度、颈淋巴结转移情况及BTG1表达均是影响口腔鳞癌预后的危险因素。结论:BTG1在口腔鳞癌中低表达,其表达与口腔鳞癌的TNM分期、分化程度有关。

关键词: B细胞易位基因1, BTG1, 口腔鳞状细胞癌

Abstract: PURPOSE: To investigate the expression and clinical significance of B cell translocation gene 1 (BTG1) in oral squamous cell carcinoma(OSCC). METHODS: Immunohistochemical staining was used to detect the expression of BTG1 protein in 78 cases of OSCC tissues, 78 adjacent tissues, 20 normal oral mucosa tissues, and 80 cervical lymph nodes. Western blot and real-time quantitative PCR were used to detect BTG1 protein and mRNA expression levels in 78 OSCC tissues and adjacent tissues. Kaplan-Meier survival analysis, Log rank test and Cox regression analysis were performed with SPSS 21.0 software package. RESULTS: The expression level of BTG1 in OSCC and cervical positive lymph nodes was significantly lower than that in normal tissues and negative lymph nodes adjacent to the cancer, and the expression of BTG1 in poorly differentiated OSCC was significantly lower than that in highly differentiated OSCC (P<0.05); Survival analysis showed the progression-free survival (PFS) and overall survival time(OS) of BTG1 low-expression group were significantly lower than those of high-expression group (P<0.05). Cox regression analysis showed that the degree of tumor differentiation, cervical lymph node metastasis, and BTG1 expression all affected patients' prognosis. CONCLUSIONS: BTG1 is lowerly expressed in OSCC, with expression related to TNM stage and differentiation of OSCC but no relation with gender, age, and tumor location, including that BTG1 may be involved in the occurrence, development and prognosis of OSCC.

Key words: B-cell translocation gene 1, BTG1, Oral squamous cell carcinoma

中图分类号:

R782

靳能皓, 南欣荣, 闫星泉. BTG1在78例口腔鳞癌中的表达及临床意义[J]. 上海口腔医学, 2021, 30(2): 140-144.

JIN Neng-hao, NAN Xin-rong, YAN Xing-quan. Expression and clinical significance of BTG-1 in 78 patients with oral squamous cell carcinoma[J]. Shanghai Journal of Stomatology, 2021, 30(2): 140-144.

参考文献

[1] Siegel R, Ward E, Brawley O, et al.Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths[J]. CA Cancer J Clin, 2011, 61(4): 212-236.
[2] 邹尧, 张丽, 刘晓明, 等. 儿童ETV6/RUNX1阳性急性淋巴细胞性白血病基因拷贝数变异的临床研究[J]. 中华儿科杂志, 2016, 54(3): 209-213.
[3] Waanders E, Scheijen B, vanderMeer LT, et al. The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution[J]. PLoS Genet, 2012, 8(2): e1002533.
[4] Li W, Zou ST, Zhu R, et al.B-cell translocation 1 gene inhibits cellular metastasis-associated behavior in breast cancer[J]. Mol Med Rep, 2014, 9(6): 2374-2380.
[5] 姜润学, 胡万宁, 孙国贵, 等. BTG1对喉癌细胞增殖和凋亡的影响及其机制研究[J].中国癌症杂志, 2015, 25(12): 959-965.
[6] 高明, 刘丽英, 李晟磊, 等. 食管鳞状细胞癌组织中BTG-1的表达及其对食管鳞状细胞癌细胞株EC9706凋亡的影响[J].中国医药导报,2019, 16(7): 7-10,182.
[7] Rimokh R, Rouault P, Wahbi K, et al.A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(8;12)(q24;q22) translocation in a case of B-cell chronic lymphocytic leukemia[J]. Genes Chromosomes Cancer, 1991, 3(1): 24-36.
[8] Yuniati L, van der Meer LT, Tijchon E, et al. Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress[J].Oncotarget,2016, 7(3): 3128-3143.
[9] Micheli L, Ceccarelli M, Farioli-Vecchioli S, et al.Control of the normal and pathological development of neural stem and progenitor cells by the PC3/Tis21/Btg2 and Btg1 genes[J]. J Cell Physiol, 2015, 230(12): 2881-2890.
[10] Chen Y, Wang C, Wu J, et al.BTG/Tob family members Tob1 and Tob2 inhibit proliferation of mouse embryonic stem cells via Id3 mRNA degradation[J]. Biochem Biophys Res Commun, 2015, 462(3): 208-214.
[11] Lorda-Diez CI, Montero JA, Garcia-Porrero JA, et al.The tumor suppressor BTG1 is expressed in the developing digits and regulates skeletogenic differentiation of limb mesodermal progenitors in high density cultures[J]. Cell Tissue Res, 2016, 364(2): 299-308.
[12] Sun GG, Wang YD, Cheng YJ, et al.The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis[J]. Mol Biol Rep, 2014, 41(9): 5979-5988.
[13] Sheng SH, Zhao CM, Sun GG, et al.BTG1 expression correlates with the pathogenesis and progression of breast carcinomas[J]. Tumour Biol, 2014, 35(4): 3317-3326.
[14] 韩小辉, 连亚军. B细胞易位基因1在脑胶质瘤组织中的表达及意义[J].中国实用神经疾病杂志, 2017, 20(8): 5-9.
[15] 曾宪清, 吴勤祥, 张晓勇, 等. BTG1在胃癌中的表达及其临床意义[J].安徽医科大学学报, 2018, 53(7): 1106-1109.
[16] 曹倪豪, 陈明. BTG1在肾透明细胞癌组织中的表达及对786-O细胞株增殖和凋亡的影响[J]. 东南大学学报(医学版), 2011, 30(4): 583-587.
[17] Zhang SQ, Yang Z, Cai XL, et al.miR-511 promotes the proliferation of human hepatoma cells by targeting the 3'UTR of B cell translocation gene 1 (BTG1) mRNA[J]. Acta Pharmacol Sin, 2017, 38(8): 1161-1170.
[18] He C, Yu T, Shi Y, et al.MicroRNA 301A promotes intestinal inflammation and colitis-associated cancer development by inhibiting BTG1[J].Gastroenterology, 2017, 152(6): 1434-1448.
[19] Wang Y, Sun W, Yang J, et al.PUM2 promotes glioblastoma cell proliferation and migration via repressing BTG1 expression[J]. Cell Struct Funct, 2019, 44(1): 29-39.
[20] Zhang ZZ, Qin XH, Zhang J.MicroRNA-183 inhibition exerts suppressive effects on diabetic retinopathy by inactivating BTG1-mediated PI3K/Akt/VEGF signaling pathway[J]. Am J Physiol Endocrinol Metab, 2019, 316(6): e1050-e1060.

BTG1在78例口腔鳞癌中的表达及临床意义

Expression and clinical significance of BTG-1 in 78 patients with oral squamous cell carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	赵娇, 隋佰延, 刘昕, 阮敏. 口腔鳞状细胞癌免疫相关预后风险模型的构建与验证[J]. 上海口腔医学, 2024, 33(4): 345-353.
[2]	刘文静, 李梦琦, 崔祥, 汪俊兰. circ_0000326靶向miR-567对口腔鳞状细胞癌HSC3细胞增殖、侵袭及迁移的调控效应[J]. 上海口腔医学, 2023, 32(6): 590-596.
[3]	陈兴金, 范然怡, 陶识丞, 薛睿, 文旭涛, 麦华明. 颈淋巴清扫术保留胸锁乳突肌与否对晚期口腔鳞癌预后的影响[J]. 上海口腔医学, 2023, 32(6): 609-614.
[4]	叶婷婷, 陈蔚华, 裴婧, 贾云香, 吴海莹. NEK2与EMT相关分子在口腔鳞状细胞癌中的表达及临床意义[J]. 上海口腔医学, 2023, 32(6): 640-644.
[5]	陈娟, 曹若妍, 刘洋, 洪鹏宇, 唐瞻贵. TNFAIP6在口腔疣状癌与口腔鳞状细胞癌中的表达及其与临床病理的关系[J]. 上海口腔医学, 2022, 31(2): 167-172.
[6]	王科, 彭国光, 谭玉莲, 何善志, 罗翠芬. miR-99a对口腔鳞癌增殖能力的影响[J]. 上海口腔医学, 2021, 30(1): 44-49.
[7]	黄丹妮, 陈文鑫, 熊浩峰, 胡鑫, 毛婷, 苏彤. 口腔鳞状细胞癌患者术后服用二甲双胍对预后的影响[J]. 上海口腔医学, 2021, 30(1): 61-65.
[8]	郑晶, 李天客, 包阳, 张素欣. Spindly和Bub3在口腔鳞状细胞癌中的表达及意义[J]. 上海口腔医学, 2020, 29(5): 528-532.
[9]	达雨, 杨震, 夏苗苗, 王梦佳. Ki-67、PI3K、Beclin1在口腔鳞癌组织中的表达及意义[J]. 上海口腔医学, 2020, 29(1): 75-79.
[10]	王培, 汤春波, 李斌, 傅宗云. LncTUG1通过靶向miR-212-3p对口腔鳞状细胞癌细胞NK细胞杀伤敏感性的影响[J]. 上海口腔医学, 2019, 28(6): 567-571.
[11]	杨宗澄, 黄海燕, 徐欣. 长链非编码RNA PCAT-1在口腔鳞状细胞癌中的表达及临床意义[J]. 上海口腔医学, 2019, 28(1): 67-70.
[12]	涂敏松, 李逸松, 张雄. YAP、TAZ蛋白在口腔鳞状细胞癌中的表达及意义[J]. 上海口腔医学, 2018, 27(4): 415-418.
[13]	李少明, 高岭, 任文豪, 薛令法, 许尧祥, 岳金, 郅克谦. 功能性与根治性颈淋巴清扫术在早期口腔鳞状细胞癌治疗中的疗效比较[J]. 上海口腔医学, 2017, 26(3): 305-308.
[14]	吴宁, 陆瑛, 梁继宗. Survivin和hsa-miR-542-3p在口腔鳞状细胞癌中的表达和相关性分析[J]. 上海口腔医学, 2016, 25(6): 720-724.
[15]	蒋丽兰, 赵娅军, 李勇. TGF-βRⅡ和NF-κB在口腔鳞状细胞癌的表达及临床意义[J]. 上海口腔医学, 2016, 25(6): 729-733.